Carnival Leads Cruise Stocks Lower on Weak 3Q Outlook

23 Jun 2026 · 25 min · 17 chapters

Ask about this episode

Ask anything about it. ChatGPT or Claude reads this page and answers with the times it was said.

Connect VO and ask about every podcast you hear, including the moments you saved. Add to ChatGPT · Add to Claude

In short

Carnival Leads Cruise Stocks Lower on Weak 3Q Outlook.

Guests

Brian Negri, senior gaming and lodging analyst at Bloomberg Intelligence; Madison Miller, healthcare reporter at Bloomberg News (later segment). Negri says Carnival’s shares fell ~5% after earnings due to a weaker 3Q outlook tied to the Iran war’s duration affecting gas prices, perceptions of air travel, and eastern Mediterranean itineraries. He claims bookings remain resilient: ~93% booked for 2026, positive yield growth, and early indications for next year. He notes Carnival is historically not fully fuel-hedged (uses collars), so results track Brent/bunker fuel moves; easing crude could help. He cites industry supply growth around mid-single digits, with Carnival adding only ~1% capacity in 2026. He contrasts broad cruise strength with “K-shaped”/“C-shaped” consumer dynamics, and points to luxury niches like Viking/rivers doing well. Miller discusses Eli Lilly’s GLP-1 boom (Zepbound/Mounjaro), crediting CEO Dave Ricks for speeding development and price cuts, and describing Lilly’s strategy to fund future pipelines via R&D, acquisitions, and AI (NVIDIA partnership).

Written by AI. May contain mistakes. Listen to the episode to check what was said.

Chapters

Tap a time to open that second in VO

Carnival Cruise Lines Earnings Report

0:00 to 0:17

Discussion around disappointing earnings from Carnival Cruise Lines.

“At Brookfield, you can own wealth that's measured in generations.”

Carnival Cruise Lines Earnings Report

1:54 to 2:24

Discussion around disappointing earnings from Carnival Cruise Lines.

“Carnival Cruise Lines reported some numbers a little bit disappointing.”

Impact of the War on Travel

2:24 to 3:38

Analyzing how geopolitical conflicts affect cruise bookings and air travel.

“I think the change perhaps was the war in Iran clearly had an effect.”

Fuel Costs and Industry Resilience

3:38 to 4:48

Exploring fuel costs' impact on cruise lines and their resilience in the market.

“Some of them do Carnival historically is not hedged.”

Capacity Growth and Market Dynamics

4:48 to 6:16

Discussing capacity growth in the cruise industry and market dynamics.

“What I noticed sitting on the beach of Aruba is the ship's engine, even when they're docked, it's running.”

Luxury Segment in Cruise Industry

6:16 to 7:12

Examining the performance of the luxury cruise segment amidst economic changes.

“I'm going on my first cruise in October.”

Current Trends in Vegas

7:12 to 7:55

Insights into the Las Vegas market's performance and stability.

“Vegas is better than last year, I think, is one way to look at it.”

Current Trends in Vegas

8:04 to 9:25

Insights into the Las Vegas market's performance and stability.

“So there's a lot of noise about AI, but time's too tight for more promises.”

Current Trends in Vegas

9:28 to 9:49

Insights into the Las Vegas market's performance and stability.

“Brokered services by Open to the Public Investing, Inc., member FINRA, and SIPC.”

Elon Musk's Impact on Investment Strategies

14:03 to 16:11

Explore how Elon Musk influences investor perceptions and bond markets.

“And with bonds, if you're right, you get paid back par.”
Show all 17 chapters

Elon Musk's Impact on Investment Strategies

16:46 to 17:33

Explore how Elon Musk influences investor perceptions and bond markets.

“If you're actively involved in your portfolio, you probably catch yourself repeating the same actions, buying the dip, manually sweeping idle cash, putting on a hedge.”

SpaceX's Market Position Post-Debut

18:30 to 22:32

Analyze SpaceX's valuation and market position after its public debut.

“Eastern on Apple CarPlay and Android Auto with the Bloomberg Business App.”

Eli Lilly's Transformation and Market Strategy

22:32 to 28:01

Learn about Eli Lilly's evolution and how weight loss drugs revived the company.

“And to your point about OpenAI, yes, they've lost momentum.”

The Rise of GLP-1 Drugs and Eli Lilly's Strategies

28:01 to 30:14

Explore the development and market strategies of GLP-1 drugs by Eli Lilly.

“Because, you know, over time, these drugs don't come out of thin air.”

Eli Lilly's Future and Market Challenges

30:15 to 32:08

Discuss Eli Lilly's strategies for sustaining success amidst patent expirations and competition.

“How does Eli Lilly plan to deal with that with its weight loss drugs?”

Eli Lilly's Future and Market Challenges

32:41 to 33:07

Discuss Eli Lilly's strategies for sustaining success amidst patent expirations and competition.

“Ask yourself, what are your best people spending their time on right now?”

Eli Lilly's Future and Market Challenges

33:11 to 33:31

Discuss Eli Lilly's strategies for sustaining success amidst patent expirations and competition.

“I don't know if you knew this, but anyone can get the same premium wireless for$15 a month plan that I've been enjoying.”
Hear the part that matters, and keep it.Open this episode in VO. Double tap your headphones to save a moment as you listen.
Get VO free

Transcript

Automatic transcript. May contain errors.

0:00At Brookfield, you can own wealth that's measured in generations. For 125 years, we've built long-term wealth through expertise, discipline, and a clear vision for the future, providing investors access to alternative strategies built for what's next. Brookfield. Own what's next. Learn more at brookfield.com. This is not an offer to sell or investment advice. Investing involves risks, including loss of capital. Never bet against American grit or American energy. Through innovation, Venture Global is not only building some of the largest energy facilities in the world right here in the United States, but delivering American energy at a fraction of the cost and a fraction of the time.

0:42So while others are busy talking, we're busy building. That's Venture Global. That's unstoppable energy.

0:53Scarlet Fu:Small businesses are the pulse of every community. They bring people together, create opportunities, and drive growth. Chase for Business helps business owners like you with personalized guidance and convenient digital tools all in one place. With that guidance and your determination, you can take your business farther and help build a brighter future for your community. Learn more at chase.com slash business. Chase for Business. Make more of what's yours. The Chase mobile app is available for select mobile devices. Message and data rates may apply. JPMorgan Chase Bank, N.A., member FDIC. Copyright 2026, JPMorgan Chase and Company.

1:53Scarlet Fu:on YouTube. Carnival Cruise Lines reported some numbers a little bit disappointing. Stock trading down about 5 % here today. I think Michael Barr, Bloomberg's Michael Barr was on a Carnival Cruise Line trip last week, and he goes crazy there. We know Charlie Pellett, big cruise guy himself. So there's a lot of cruises around here in Bloomberg. Brian Negri joins us here, senior gaming and lodging analyst for Bloomberg Intelligence. Talk to us about Carnival Cruise Lines. And what did you learn on the earnings report? So, I mean, they're still looking for some yield growth, positive yield growth this year.

2:27I think the change perhaps was the war in Iran clearly had an effect. Affected gas prices, affected air travel and the perception of the ease of air travel. And some itineraries in the eastern Mediterranean. I think the big change from their perspective was how long it lasted. You know, it comes down to, I think when they last gave guidance in March, they were not expecting we'd still be talking about this into May and June. So things have gotten better in June. But I think like, you know, May was a bit of a setback in terms of the duration of a conflict. Yeah. Yep. So what are they finding about, I guess, just, you know, the typical bookings, I think, in the Caribbean and all that kind of stuff?

3:05How do they hold? How are they holding up? Because I kind of think when I think cruising, that's a big part of it. Yeah. I mean, overall, quite well. I mean, with the exception of the disruptions I talked about, we're still seeing positive yield growth, which in an uncertain economy is, I think, a good thing. They are, I believe they said 93 % booked for this year, and they've got some positive early indications for next year. So the industry is still proving to be quite resilient, notwithstanding the fact that you've got the disruption from the war itself, which was a factor. So on the fuel side, I know the airlines, by and large, do not hedge.

3:42Do the cruise companies hedge? Some of them do Carnival historically is not hedged. Some of them do have hedges. They have collars in places in the case of Carnival. You know, when we last heard their guidance, they were providing guidance based on certain expectations about Brent fuel. At the time they last spoke a couple months ago, fuel prices were above that. Now it's below that. So it's very much tied to the trajectory of this conflict. What's fuel as a part of their cost structure of a typical cruiser? Remember what the exact percentage. It's pretty big, right? It's a pretty Philly large percentage.

4:18So this is something, I mean, they've been dealing with a headwind for the last several months. May become a little bit of a tailwind on the downside. Could be. I mean, I think they went into with some assumptions about forward contracts where run prices that were, you know,$80,$90. And now as crude oil eases, it could work the other way. So certainly the relaxation or the easing of Brent fuel, even though they use bunker fuel, a certain grade of it, is a positive for them. What I noticed sitting on the beach of Aruba is the ship's engine, even when they're docked, it's running. Because I see the smoke coming out of the smokestack 24-7, I guess just to run the thing.

5:00So they burn fuel 24-7 here. So that's a big issue. Talk to us about capacity in the industry. Are we adding capacity, taking it out? So the industry overall, we're looking at something like 4-ish percent mid-single-digit supply growth. Carnival is an exception in as much as their growing capacity in 2026 by only 1%. So they've taken a much more measured approach, which I think in this environment seems quite prudent. They will be adding maybe one or two ships a year, balanced between the Caribbean and the rest of the world. But 0.9 % supply growth for them for this year is obviously quite measured.

5:37We're seeing lots of parts of the economy. The higher end doing well, the lower end not so much. And I know that the cruise lines, they have different brands, just like the hotels have different brands that cater to different income levels. Are you guys seeing that dynamic in the cruise? I don't know if we're seeing that much of a parsing between the upper and lower end with respect to cruising specifically. You're absolutely right for hotels. For a while, we referred to the K-shaped economy. And now it's more like the C-shaped economy. As Hilton CEO earmarked that with the lower end now coming back.

6:12I think for cruises, the strength has been fairly broad-based. What's really driving it, if you're in the Caribbean, it's these island destinations that help drive pricing. Interesting. Yeah. I'm going on my first cruise in October. A Viking cruise, that stock's up 40 % this year. It's doubled over the last 12 months. What's going on there? Besides having my deposit impact the earnings. That definitely helps. Yes. I think that the niche they're in, which is that luxury segment, it is a niche market, the river cruise market, and the somewhat smaller ocean cruise presence has done quite well. So that may be an example of what you're talking about, where the high-end is doing quite well.

6:48And that's a high-end consumer, clearly more luxury-focused. So while we don't see those patterns necessarily broad-based across the sector, they are high-end, kind of river cruise-oriented luxury niche. For what I'm paying, this thing better be all-inclusive. I'm going to go back and check. I'm not going to sit there and pay for every cocktail, a glass of rosé. Vegas, real quick, 30 seconds. How's Vegas doing? Vegas is better than last year, I think, is one way to look at it. Certainly we have still see on the lower end of the market where you do see that kind of bifurcation between high and low end in Vegas.

7:24A bit more stability there where visitation is kind of flattened out. Pricing is a bit better. 2025 was a rougher year where you had tougher event comparisons and pressure on midweek leisure stays. So it's a bit more stabilized and better this year.

7:39Scarlet Fu:Stay with us. More from Bloomberg Intelligence coming up after this. at brookfield you can own wealth that's measured in generations for 125 years we've built long-term wealth through expertise discipline and a clear vision for the future providing investors access to alternative strategies built for what's next brookfield own what's next learn more at brookfield.com this is not an offer to sell or investment advice investing involves risks including loss of capital So there's a lot of noise about AI, but time's too tight for more promises. So let's talk about results. At IBM, we work with our employees to integrate technology right into the systems they need.

8:18Now, a global workforce of 300 ,000 can use AI to fill their HR questions, resolving 94 % of common questions. Not noise. Proof of how we can help companies get smarter by putting AI where it actually pays off, deep in the work that moves the business. Let's create smarter business. IBM. Support for the show comes from public.com. If you're actively involved in your portfolio, you probably catch yourself repeating the same actions. Buying the dip, manually sweeping idle cash, putting on a hedge. On public, you can now create AI agents that handle all these tasks on your behalf. Just describe what you want to do in plain English.

8:56Like, if the VIX hits 25, buy a put option on the S &P 500. or if my cash balance goes above$20 ,000, move the excess into my direct index. You approve the workflow and your agent handles the rest. Monitoring the market, watching for your conditions and executing your strategies exactly as defined. An investing platform driven by your intent, not just your clicks. You can also get full read and write access to your account via the public API. Go to public.com slash market and fund your account in five minutes or less. That's public.com slash market. Paid for by Public Investing. Brokered services by Open to the Public Investing, Inc., member FINRA, and SIPC.

9:39Advisory services by Public Advisors, LLC, SEC Registered Advisor. Complete disclosures available at public.com slash disclosures.

9:49Scarlet Fu:You're listening to the Bloomberg Intelligence Podcast. Catch us live weekdays at 10 a.m. Eastern on Apple CarPlay and Android Auto with the Bloomberg Business App. Listen on demand wherever you get your podcasts. or watch us live on YouTube. We've been talking all morning and really for the last few days, Paul, about SpaceX and where this stock has been moving. It's currently up, so that four-day decline did not come to pass. It has stopped at three days for now, but it was a painful three-day slump, down about 22%, if I recall correctly. So, you know, definitely a repricing of the initial euphoria following the IPO.

10:26Yeah, having done a bunch of these equity deals, it just felt like the stock was trying to find a home here. And that's maybe like who really wants to own this thing long term and who's just playing the deal a little bit. So here we are.

10:36Scarlet Fu:All right. And of course, we know that the same time SpaceX, the company, has announced a big, big bond sale as well. Getting ready to sell investment grade bonds for the first time to refinance a bridge loan, but also, let's face it, to fund this AI build out as well. So for that, of course, we need to bring in our in-house expert on tech and bonds, and that is Robert Shiffman. He's our senior tech credit analyst here for Bloomberg Intelligence. Rob, what will you be watching for and listening for the next couple of hours here when it comes to this SpaceX bond debut? I think I already know the story.

11:10Bondholders are going to welcome SpaceX with arms wide open. You know, nobody owns this deal, right? There's hundreds of billions of AI-related tech bonds that have been issued this year. There's hundreds of billions of tech bonds outstanding. but this is an inaugural offering. So everyone's going to want a little piece. And quite frankly, the difference between how SpaceX is going to trade in the bond market versus the equity market couldn't be much different. The valuations from the equity side may seem really, really lofty. I think it's the reverse for the credit markets. These bonds are going to come wildly wide to where comparably rated investment grade names trade.

11:52And I think that's going to attract a lot of attention.

11:55Scarlet Fu:Did it surprise you that it got investment grade ratings, even though it doesn't have much of a track record, almost no track record as a publicly traded company? I mean, one of our Bloomberg News stories or other reporters have pointed out that NVIDIA was given the same rating and NVIDIA had a much longer track record as a publicly traded company than SpaceX does at the moment. No, I wasn't surprised. Quite frankly, I think the plans for the buildout have been reasonably well known. So for people who are looking at the SpaceX equity IPO, they had a really good understanding of how much money was going to be spent over the next handful of years.

12:32And quite frankly, you can't have negative free cash flow. That's 20, 30, 40 billion dollars annually without access to low cost, cheap capital. A big pool that was equities. They raised 85 billion dollars of equity, but they're probably going to need another$100 billion of debt. So if you had plans to borrow that much and thought you can do it in the junk markets, you'd be thought of as crazy. So I think this is pretty well understood. I do get it why people say, how are these ratings so high? And I think you just need to look into the future a little bit and look at the past. One is they're sitting on$100 billion of cash.

13:11Two is they're committed to IG ratings and reasonably low leverage. Three is their liquidity profile looks fantastic. They have access to huge pools of both equity and debt capital, and their burn rate, it's going to take them three or four years to even get through the amount of capital that they have today. So do you want to question where this company might be in five years and what leverage is going to look like, and are they going to be successful? I think it's a good debate, and I think when you're comping, are they an aerospace and defense company? Are they a communications company? Are they an AI tech company?

13:42All of that creates, I think, more opportunity for bondholders because the bond deal gets priced probably wider than inherently it should. There's definitely an Elon factor, a positive Elon factor in the equity markets. Is this such a thing with you credit guys who are a little bit more sober? I hear so much about how everyone in the AI world would rather just invest in equity because if they're right, there's huge upside. And with bonds, if you're right, you get paid back par. And if you're wrong, you get crushed. That's actually silly. Every basis point in the fixed income markets make a huge difference.

14:16And if you're coming at spreads that are 100 basis points wide to peers, that pays for the Elon Musk risk. I would actually argue there's Elon Musk reward. I know some people have cringed at this, but I think Elon Musk is to today's generation what Warren Buffett was to the prior generation in terms of value creation. I think the future that he sees is a lot different than what a lot of other people see. I think his ability to execute is much higher than what people are giving credit for. Quite frankly, he does get a lot of credit and it's a$2 trillion equity market cap. So, you know, for everyone who wants to poo-poo all the risk, you know, people are riding the Elon wave.

14:55Scarlet Fu:Okay. So the bond market is giving Elon Musk the benefit of the doubt. It sounds like, does the bond market give any other CEO, founder, company that same level of benefit? Well, the difference between SpaceX and the rest of these other AI companies, you know, we've said this so many times before, is the other names are basically the Mount Rushmore credits. You know, they're AA's and AAA's. So they inherently have built-in credibility because they have so much financial flexibility. So what if Amazon borrows another$100 billion or if Alphabet borrows, you know,$150 billion? The balance sheet's going to be fine.

15:31Here, you know, you're starting with a company that doesn't have a lot of EBITDA. It's big negative free cash flow. doesn't have this long, long track record of success. So ultimately what happens, listen, spreads are at historically tight levels. Everyone is looking for the next basis point to outperform. If you price something right, it's going to sell. These bonds look like they're going to be priced dramatically wide to triple B alternatives. So even if the long-term you think there's real question marks in the short term, you're going to try to get bonds. You're going going to buy bonds now and ask questions later.

16:08And I think that's going to support this deal.

16:10Scarlet Fu:Stay with us. More from Bloomberg Intelligence coming up after this. What if you could have more wins, more support, more sound effects? At LPL Financial, we like the sound of that because LPL offers more. Advisors, what if you could have more ways to help your clients? Ready to invest? What if you could find an advisor that really understands you. When it comes to your finances, your business, your future, at LPL, we ask, what if you could? Paid advertisement. Investing involves risk, including potential loss of principal. LPL Financial LLC member FINRA SIPC. Support for the show comes from public.com.

16:48If you're actively involved in your portfolio, you probably catch yourself repeating the same actions, buying the dip, manually sweeping idle cash, putting on a hedge. On public, you can now create AI agents that handle all these tasks on your behalf. Just describe what you want to do in plain English. Like, if the VIX hits 25, buy a put option on the S &P 500. Or, if my cash balance goes above$20 ,000, move the excess into my direct index. You approve of the workflow and your agent handles the rest. Monitoring the market, watching for your conditions, and executing your strategies exactly as defined.

17:24An investing platform driven by your intent, not just your clicks. You can also get full read and write access to your account via the public API. Go to public.com slash market and fund your account in five minutes or less. That's public.com slash market. Paid for by Public Investing. Brokered services by Open to the Public Investing, Member FINRA and SIPC. Advisory services by Public Advisors, LLC, SEC Registered Advisor. Complete disclosures available at public.com slash disclosures. Ask yourself, What are your best people spending their time on right now? Expense reports, receipt chasing, month-end close that takes weeks.

18:04You become what you spend on, and that's not what you're building toward. Brex is the intelligent finance platform that eliminates that work before it starts. AI agents that handle the manual stuff automatically, so your team can spend their time on what actually compounds. It's time to get Brex AF. Learn more at brex.com slash AF.

18:27Scarlet Fu:You're listening to the Bloomberg Intelligence Podcast. Catch us live weekdays at 10 a.m. Eastern on Apple CarPlay and Android Auto with the Bloomberg Business App. Listen on demand wherever you get your podcasts or watch us live on YouTube. All right. Well, we talked a little bit about SpaceX and it's a company that we kind of can't ignore given the market debut it had over the last couple of days. And Mandeep Singh is here with us. He is our go to guy in all things tech. He is our global tech research head here at Bloomberg Intelligence. Mandeep, you look at what is happening with SpaceX, and Paul put it really well in that it's just kind of trying to find its place.

19:06Scarlet Fu:People are trying to figure out what the right price looks like for a company like this after all the fanfare and then, you know, the flushing out maybe of some of the early investors. What do you see as the most enduring narrative for this company now that it's just over a week into its life as a publicly traded company? Well, I think clearly during the roadshow, people got really excited about the orbital data centers and the space launches. But we know they don't generate any revenue right now. And I think people are coming to the realization that this requires a lot more upfront capital, which is why they are doing that bond issuance.

19:46And then there will be some equity issuance to close out the cursor acquisition. So they will be adding, you know, 3 % more stock to close out that deal. And look, if you are an investor in this company who is getting diluted right now, it's reasonable to say some people, you know, aren't there for the long term. And there is a shakeout that's going on. And we'll figure out who wants to believe in the company long term because this is not a free cash flow or a stock buyback story anytime soon. All right, switching gears to Google here. Get some AI dudes are departing Google. I mean, should Google be worried about this?

20:29Some of their talent leaving? I think so. I mean, the fact that the market cap dropped by$250 billion probably is an exaggeration. So it just goes to show they probably should have paid these guys anything to retain them. But look, when it comes to frontier models, there is no doubt that Anthropic is ahead. even OpenAI has been releasing their models at a faster pace. And this space is all about leapfrogging your competitors when it comes to the model intelligence layer. I mean, Anthropics, Mythos release, everyone is freaking out in terms of the capabilities of the model to the extent that the government has blocked access.

21:11Why? Because they're at the frontier of intelligence. So does Google have an equivalent model? No. The answer is no. And when will they be releasing it? We don't know, which is why they will end up losing talent because everyone now believes Anthropic is at the frontier and Anthropic seems to be gaining a lot of talent. It's always been a talent driven technologies, you know, but it feels more blood bloody than

21:38Scarlet Fu:ever has, right? I mean, in terms of the pecking order of companies that have their pick for talent, Anthropic, you point out, is at the top. Is OpenAI still up there? I mean, OpenAI has lost a little bit of its momentum to Anthropic. Where does SpaceX rank? Where does, you know, the hyperscalers, where did they land? And that's a great question. So which is why that acquisition of Cursor was so timely? I know the stock is dropping last three days, but had it not been for the Cursor acquisition, I bet you the stock would be under$100. So Cursor really did make a difference in terms of, one, getting that coding agent use case and, you know, giving a narrative that they can scale this and also the talent.

Read the full transcript

22:20I mean, Cursor co-founders are probably the smartest guys in AI and highly sought after. So I hope they're able to retain that talent that they got from Cursor, but clearly a great acquisition. And to your point about OpenAI, yes, they've lost momentum. Remember, OpenAI ended up bringing on the co-founder or the founder of OpenClaw. OpenClaw was like the next big thing at the start of the year. Everyone was talking about what is going to be that agentic platform on your smartphones and its devices. OpenClaw co-founder went to OpenAI. And, you know, that's where it makes a huge difference where these guys end up because they have the vision.

23:03And if they find Anthropic to be the place or open AI, that makes a huge difference.

23:09Scarlet Fu:Stay with us. More from Bloomberg Intelligence coming up after this. Support for the show comes from Public.com. If you're actively involved in your portfolio, you probably catch yourself repeating the same actions. Buying the dip, manually sweeping idle cash, putting on a hedge. On Public, you can now create AI agents that handle all these tasks on your behalf. Just describe what you want to do in plain English, like if the VIX hits 25, buy a put option on the S &P 500. Or if my cash balance goes above$20 ,000, move the excess into my direct index. You approve of the workflow and your agent handles the rest.

23:47Monitoring the market, watching for your conditions, and executing your strategies exactly as defined. An investing platform driven by your intent, not just your clicks. You can also get full read and write access to your account via the public API. Go to public.com slash market and fund your account in five minutes or less. That's public.com slash market. Paid for by Public Investing. Brokered services by Open to the Public Investing, Inc., Member FINRA and SIPC. Advisory services by Public Advisors, LLC, SEC Registered Advisor. Complete disclosures available at public.com slash disclosures. If your best finance people are doing expense reports, chasing receipts, or spending time on month-end close, it's time to get Brex AF, a gentic finance that eliminates that work before it starts.

24:36Learn more at brex.com slash AF. Ryan Reynolds here from Mint Mobile, with a message for everyone paying big wireless way too much. Please, for the love of everything good in this world, stop. With Mint, you can get premium wireless for just$15 a month. Of course, if you enjoy overpaying, no judgments, but that's weird. Okay, one judgment. Anyway, give it a try at MintMobile.com slash switch.

25:01Scarlet Fu:Upfront payment of$45 for a three-month plan, equivalent to$15 per month required. Intro rate first three months only. Then full price plan options available. Taxes and fees extra. See full terms at MintMobile.com. You're listening to the Bloomberg Intelligence Podcast. Catch us live weekdays at 10 a.m. Eastern on Apple CarPlay and Android Auto with the Bloomberg Business App. Listen on demand wherever you get your podcasts or watch us live on YouTube. You know, we love the big take stories. They come out every day on the Bloomberg Terminal and Bloomberg.com. They're really fascinating stories.

25:32Deeply resourced, deeply sourced, lots of cool stuff. This is a good one today. How Eli Lilly got huge by making us thin. Remember, Eli Lilly, they're the maker of ZepBound. I think that's one of the big, big, big GLP-1 drugs out there. And it's just a massive market for global health. Now, Moon Charo. Now, Moon Charo. Yep, it's just awesome. Madison Miller joins us here, healthcare reporter for Bloomberg News. I know you guys did a big, big take story on this, Madison, about Eli Lilly and how they plan to keep the GLP-1 boom going. Talk to us about what you found out. Yeah, definitely. Thank you for having me on to talk about this.

26:10I mean, Lilly is an amazing story. The company is 150 years old. There's only a handful of American companies that are still still sort of look the same as they did 150 years ago. And so Lilly is one of them. It's a pretty good American company story, but they've really transformed over the last few decades. They had you know, they were one of the first to develop the polio vaccine treatments for covid. They've had antibiotics, penicillin, many, many things over the years and have been at the forefront of many different medical breakthroughs. But they had sort of a dry spell in between that a couple decades ago that really made it hard.

26:52I mean, their stock price was down. There was CEO turnover. But now we've seen weight loss drugs really pull them out of that and make them into this trillion dollar company and the most valuable health care company in the world. So it's a pretty amazing transformation and story of what happens to a company when they have a huge blockbuster product like these weight loss drugs have been.

27:15Scarlet Fu:Yeah, I'm just thinking about, you know, as recently as June of 2020, we're looking at Pfizer as kind of the shining star of the pharma world because of its COVID vaccine. And Eli Lilly, you know, did not come up in the same kinds of conversations. What you've done in your story is really highlight how much has changed between, say, 2017 to 2026. Dave Ricks became CEO of Eli Lilly back in 2017. And at the time, the pharma industry was not held in high esteem by Americans. There was a lot of mistrust directed at the pharma companies. He has helped turn that around. I wonder how much of the credit he deserves versus what was kind of already in the pipeline at Eli Lilly.

27:56Scarlet Fu:and he was at the helm when it all came to fruition? Yeah, no, that's a great question, Scarlett. Because, you know, over time, these drugs don't come out of thin air. And I think that that's one of the things that this GLP-1 boom really surprised people is like, it seemed like it was sort of an overnight sensation that these weight loss drugs became popular, that people started talking about them. But really scientists that both Lilly and Novo Nordisk have been working on GLP-1 drugs for several decades. And so it's something that has been going on behind the scenes for a while. But to Dave Ricks' credit, he was the one, you know, when he became CEO, he was like, we need to move as fast as possible.

28:35At the time, Lilly was one of the slowest in the industry when it came to drug development. Took them 13 to 14 years to bring a drug from their labs to an actual approved product. And there's lots of trial and error in that too. You know, most drugs don't actually make it to an approval. And so he said, you know, to all of their scientists and all of the executives at the time, like, we need to make speed the number one priority and we need to look at everything we're doing find the most promising science and then go as fast as we possibly can so that's what they did really with terzepatide which is the molecule that became manjaro and zep bound that's the active ingredient and that was sort of like the pilot that was the first time that they really did this and gave it the full speed treatment and what we saw was that they were able to bring this drug really to the market in around five years, which is a huge reduction in time from what we were seeing before with Lilly.

29:27And so they've applied that across the board now to everything. And Dave Ricks has also taken steps to make the company more consumer facing, to engage more directly with patients, to cut prices when we've been seeing a lot of outcry and a lot of attention on how expensive GLP-1 drugs are. They're still pretty expensive, maybe not necessarily super affordable for all Americans, But to Rick's credit, he's taken steps to cut the cash pay price of these drugs so that more people can afford them because we're still seeing a lot of patchy insurance coverage with these obesity medications. So he's taken he has been, you know, unafraid to take risks and to do things differently than his predecessors and then than his peers in the pharmaceutical industry.

30:13So he does deserve a lot of the credit for that. Madison, one of the challenges, I think, for managing these pharma companies and investing in these pharma companies is if you're lucky enough to get a really successful drug, sooner or later, patents expire and competition arrives here. How does Eli Lilly plan to deal with that with its weight loss drugs? Yeah, that's exactly right. And that's something Lilly's still trying to figure out. The strategy right now is to sort of deploy this cash that they have, this massive windfall from the success of its obesity medications into everything. I mean, they're infusing billions of dollars into their internal R &D programs.

30:52So, you know, focusing on the science that they have going on in their labs. But they're also looking externally. They've been on a record spending spree this year. Lilly was a company that typically didn't do as big of deals as its pharmaceutical rivals. But now we're seeing Lilly spend a lot more on other external science, acquiring different companies, doing more deals. So that's part of it. We're also seeing them spend a lot on AI. And AI is interesting in drug development because there's a lot of promise there. But so far, we haven't seen a lot of that come to fruition in terms of, you know, turning these, you know, AI finding new drugs and those coming to market and being revolutionary cures for patients.

31:32Like that's not really happening yet, but it could happen one day. And so Lily is spending on AI as well. They have a partnership with NVIDIA. They have a supercomputer at their headquarters in Indianapolis. And so they're also looking to AI and saying, if this is something that's going to revolutionize and change drug development, we want to be there. And so they're really doing everything they possibly can, but it'll be a fascinating story to watch because obviously right now we don't know what's going to happen. Lily doesn't know what's going to happen and it will be pretty incredible if they are able to sort of break out of this boom and bust cycle that every pharmaceutical company, you know, in the history has sort of had to deal with.

32:15Scarlet Fu:This is the Bloomberg Intelligence Podcast, available on Apple, Spotify, and anywhere else you get your podcasts. Listen live each weekday, 10 a.m. to noon Eastern on Bloomberg.com, the iHeartRadio app, TuneIn, and the Bloomberg Business app. You can also watch us live every weekday on YouTube and always on the Bloomberg Terminal.

32:41Ask yourself, what are your best people spending their time on right now? Expense reports, receipt chasing, month-end close that takes weeks. You become what you spend on, and that's not what you're building toward. Brex is the intelligent finance platform that eliminates that work before it starts. AI agents that handle the manual stuff automatically, so your team can spend their time on what actually compounds. It's time to get Brex AF. Learn more at brex.com slash AF. Ryan Reynolds here from Mint Mobile. I don't know if you knew this, but anyone can get the same premium wireless for$15 a month plan that I've been enjoying.

33:19It's not just for celebrities. So do like I did and have one of your assistant's assistants switch you to Mint Mobile today. I'm told it's super easy to do at mintmobile.com slash switch.

33:30Scarlet Fu:Upfront payment of$45 for three-month plan equivalent to$15 per month required. Intro rate first three months only, then full price plan options available. Taxes and fees extra. Default terms at mintmobile.com. and now another appliance triumph from our friends at grand appliance with two dogs every wash load came out covered in fur i went into grand appliance looking for a fix and they recommended the maytag top load with pet pro hair removal system they had it in stock and installed it days later and you know what it really works lint rollers are a thing of my past now great recommendations from the appliance experts shop grand appliance.com grand appliance.com Thank you.

From the publisher

Watch Paul and Scarlet LIVE every day on YouTube: http://bit.ly/3vTiACF.

Bloomberg Intelligence hosted by Paul Sweeney and Scarlet Fu 

-Brian Egger, Bloomberg Intelligence Senior Gaming and Lodging Analyst, discusses Carnival earnings. According to Bloomberg Intelligence: Carnival's outlook for 1.75% constant-currency full-year revenue-yield growth (2.25% excluding deployment and loyalty-program changes) reflects a 100-bp guidance reduction since March, due to higher airfare and gas prices amid disruption from conflict in the Middle East.

-Robert Schiffman, Senior Tech Credit Analyst for Bloomberg Intelligence, discusses SpaceX’s historic bond debut. According to Bloomberg Intelligence: SpaceX's inaugural high grade bond offering could draw heavy demand, aided by first-time issuer scarcity and demand for diversified AI-linked credit exposure. Key-person risk, large funding needs and execution challenges tied to space and AI expansion may raise questions about balance-sheet strength and cash-flow generation over time.

-Mandeep Singh, Global Tech Research Head at Bloomberg Intelligence, discusses SpaceX. After pulling off a record $86 billion IPO in mid-June and riding an initial surge, enthusiasm waned for the stock that’s been at the forefront of a retail frenzy in speculative space and AI trades. 

-Madison Muller, Bloomberg News Health Reporter, discusses the Bloomberg Big Take: “How Eli Lilly's CEO Plans to Keep the GLP-1 Boom Going.” When Dave Ricks became chief executive officer of Eli Lilly & Co. in 2017, he was facing an industry under siege. Americans held drug companies in lower esteem than airlines, law firms and even the federal government. President Donald Trump, then starting his first term, was excoriating them for their high prices. A mounting number of reports showed that soaring costs were even forcing some diabetics to ration insulin.

See omnystudio.com/listener for privacy information.

More from Bloomberg Intelligence

All 414 episodes
Carnival Leads Cruise Stocks Lower on Weak 3Q OutlookBloomberg Intelligence · 25 min
Listen in VO